Vaccinex, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 48.77 | -100% | -0.0152 | -100% |
| P/S |
|
8.37 | 33.77 | -75.21% |
|
|
| P/BV |
|
-2.06 | 4.83 | -142.76% |
|
|
| P/FCF |
|
0 | 61 | -100% |
|
|
| Ev/Ebitda |
|
-0.153 | -22.17 | -99.31% |
|
|
| Ev/S |
|
6.11 | 22.57 | -72.93% |
|
|
| Ev/FCF |
|
-0.2013 | 68.76 | -100.29% |
|
|
| E/P |
|
0 | 0.0178 | -100% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-3994.04 | 4.97 | -80429.43% | -17540.13 | -77.23% |
| ROE |
|
876.29 | 9.61 | 9016.99% |
|
|
| ROA |
|
-557.73 | 0.3443 | -162107.22% |
|
|
| ROIC |
|
0 | 7.63 | -100% |
|
|
| ROS |
|
-3552.81 | -25.17 | 14015.24% |
|
|
| ROCE |
|
990.26 | 15.45 | 6309.67% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.0108 | -3.68 | -99.7% | -0.0153 | -29.04% |
| Nеt Debt/Ebitda |
|
0.0566 | -3.44 | -101.65% |
|
|
| Debt/Ratio |
|
0.068 | 0.1986 | -65.74% |
|
|
| Debt/Equity |
|
0 | 1.66 | -100% |
|
|
| Debt/Net Income |
|
-0.0122 | 10.32 | -100.12% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.541 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2256 | -100% |
|
|
| Average dividend growth |
|
0 | 0.9598 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4928 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.56 | -100% |
|
|
| Difference from average difference in sector |
|
-0.541 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
2/10
|
8.99 | -57.64 | -115.6% | ||
| Growth impulse Ebitda in 5 years |
|
-37.51 | -90.94 | -58.75% | ||
| Growth impulse Net Income in 5 years |
|
-36.72 | -97.8 | -62.45% | ||
| Growth impulse FCF in 5 years |
|
-43.83 | -108.72 | -59.69% | ||
| Growth impulse EPS in 5 years |
|
1654.11 | -142.05 | -1264.46% |
IP Score
3.92/10
